Medtronic also recently teamed with Tempus to assess the use of artificial intelligence to identify people eligible for ...

The Society for Cardiovascular Angiography & Interventions (SCAI) has published an expert consensus statement that provides ...

Executives expect a new label indication and a hoped-for easing of hospital capacity constraints to accelerate sales this year.

The Society for Cardiovascular Angiography & Interventions (SCAI) has published an expert consensus statement that provides interventional cardiologists, cardiothoracic surgeons, and heart teams with ...

WASHINGTON—The Society for Cardiovascular Angiography & Interventions (SCAI) has published an expert consensus statement that provides ...

In particular, research on Edwards' market-leading Sapien TAVR device suggests that the learning curve is 200 cases. That's the inflection point where the physician can deliver optimal patient ...

Advt The company's lead product, transcatheter aortic valve replacement (TAVR) device, is used for minimally invasive heart surgeries. Sales from the TAVR unit rose nearly 6per cent to $1.04 ...

The Transcatheter Aortic Valve Replacement Market primarily revolves around devices designed for minimally invasive valve replacement procedures, which are increasingly preferred over traditional open ...

Minimally invasive heart procedures like transcatheter aortic valve replacement (TAVR) and MitraClip placement to treat mitral regurgitation can improve quality of life, and even be lifesaving, for ...

Edwards Lifesciences beat analysts' estimate for fourth-quarter profit on Tuesday, helped by strong demand for its artificial heart valves and other medical devices. Investors remain bullish on ...